PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain
Aug 26, 2022•1 hr 19 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.
For the best experience, listen in Metacast app for iOS or Android